Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125461073 | 12546107 | 3 | F | 2016 | 20160818 | 20160711 | 20160929 | PER | US-JNJFOC-20160623844 | JANSSEN | 0.00 | M | Y | 0.00000 | 20160929 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125461073 | 12546107 | 1 | SS | INVEGA SUSTENNA | PALIPERIDONE PALMITATE | 1 | Intramuscular | N | U | UNKNOWN;UNKNOWN | 0 | 156 | MG | INJECTION | |||||
| 125461073 | 12546107 | 2 | SS | INVEGA SUSTENNA | PALIPERIDONE PALMITATE | 1 | Intramuscular | N | U | UNKNOWN;UNKNOWN | 0 | 234 | MG | INJECTION | |||||
| 125461073 | 12546107 | 3 | SS | INVEGA SUSTENNA | PALIPERIDONE PALMITATE | 1 | Intramuscular | N | U | UNKNOWN;UNKNOWN | 0 | 234 | MG | INJECTION | |||||
| 125461073 | 12546107 | 4 | SS | INVEGA SUSTENNA | PALIPERIDONE PALMITATE | 1 | Intramuscular | N | U | UNKNOWN;UNKNOWN | 0 | 78 | MG | INJECTION | |||||
| 125461073 | 12546107 | 5 | SS | INVEGA SUSTENNA | PALIPERIDONE PALMITATE | 1 | Intramuscular | DAY 1 | N | U | UNKNOWN;UNKNOWN | 0 | 234 | MG | INJECTION | ||||
| 125461073 | 12546107 | 6 | PS | INVEGA SUSTENNA | PALIPERIDONE PALMITATE | 1 | Intramuscular | DAY 8 | N | U | UNKNOWN;UNKNOWN | 22264 | 156 | MG | INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125461073 | 12546107 | 1 | Schizophrenia |
| 125461073 | 12546107 | 2 | Schizophrenia |
| 125461073 | 12546107 | 3 | Schizophrenia |
| 125461073 | 12546107 | 4 | Schizophrenia |
| 125461073 | 12546107 | 5 | Schizophrenia |
| 125461073 | 12546107 | 6 | Schizophrenia |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125461073 | 12546107 | Abnormal behaviour | |
| 125461073 | 12546107 | Apathy | |
| 125461073 | 12546107 | Drug ineffective | |
| 125461073 | 12546107 | Fatigue | |
| 125461073 | 12546107 | Hypersomnia | |
| 125461073 | 12546107 | Language disorder | |
| 125461073 | 12546107 | Lethargy | |
| 125461073 | 12546107 | Social avoidant behaviour | |
| 125461073 | 12546107 | Therapeutic response decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125461073 | 12546107 | 1 | 20160708 | 0 | ||
| 125461073 | 12546107 | 5 | 201511 | 0 | ||
| 125461073 | 12546107 | 6 | 201511 | 0 |